Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01892410 · ClinicalTrials.gov registry record · NA

Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body Wash

A NA study, sponsored by Galderma R&D.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT01892410: Completed NA study, sponsored by Galderma R&D.

NCT01892410 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01892410, a NA study, has completed, sponsored by Galderma R&D.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

Determine if Cetaphil Restoraderm Skin Restoring Body Wash proves to be a contact sensitizer or irritant in certain individuals.

Primary Outcome

9 consecutive 24hr exposures for every Monday, Wednesday, and Friday for 3 consecutive weeks

Interventions

  • OTHER Cetaphil Restoraderm Skin Restoring Body Wash

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2012-12
Phase NA
Galderma R&D

158 total trials

What the finished NCT01892410 record still lists

NCT01892410 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Cetaphil Restoraderm Skin Restoring Body Wash is the first listed.

NCT01892410 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01892410 about?

NCT01892410 is a clinical study titled "Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body Wash". Determine if Cetaphil Restoraderm Skin Restoring Body Wash proves to be a contact sensitizer or irritant in certain individuals.

What is the current status of trial NCT01892410?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2012-12.

What interventions are being tested in trial NCT01892410?

The interventions under investigation include: Cetaphil Restoraderm Skin Restoring Body Wash (OTHER).

Who is sponsoring clinical trial NCT01892410?

This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01892410's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01892410, the US trial registry maintained by the National Library of Medicine. NCT01892410 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.